Please login to the form below

Not currently logged in
Email:
Password:

pomalidomide

This page shows the latest pomalidomide news and features for those working in and with pharma, biotech and healthcare.

BMS closes on Celgene merger after rebel investors bow out

BMS closes on Celgene merger after rebel investors bow out

the EU for the drug and follow-up Imnovid (pomalidomide) in triplet combinations for multiple myeloma.

Latest news

More from news
Approximately 6 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics